ICU Medical (ICUI) Tops Q2 EPS by 10c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall St set for lower open as AI jitters rekindle, oil gains
- Brent hits five-month high on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
- US orders diplomats to depart Saudi Arabia amid Houthi strikes
Piper Jaffray Remains Sidelined on ICU Medical (ICUI) Following Strong 2Q - PT to $119
August 9, 2016 8:38 AM EDTPiper Jaffray reiterated a Neutral rating on ICU Medical (NASDAQ: ICUI), and raised the price target to $119.00 (from $115.00), following the company's 2Q earnings report. ICUI reported revenues of $96.7M, ahead of the consensus of $89.9M. Adjusted EPS of $1.15 also outperformed expectations, compared to $1.05 consensus.... More



